{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:28:19Z","timestamp":1778279299634,"version":"3.51.4"},"reference-count":52,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"French Embassy in Hanoi"},{"name":"Pierre Fabre Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1111\/jcpt.12754","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T15:21:32Z","timestamp":1534951292000},"page":"69-77","source":"Crossref","is-referenced-by-count":26,"title":["Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis"],"prefix":"10.1155","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6916-6135","authenticated-orcid":false,"given":"Khac-Dung","family":"Nguyen","sequence":"first","affiliation":[{"name":"The National Centre of Drug Information and Adverse Drug Reaction Monitoring; Hanoi University of Pharmacy; Hanoi Vietnam"},{"name":"Laboratoire de Pharmacologie M\u00e9dicale et Clinique (Medical and Clinical Pharmacology Laboratory); Facult\u00e9 de M\u00e9decine de l'Universit\u00e9 Paul-Sabatier (Faculty of Medicine, Paul-Sabatier University); Toulouse France"},{"name":"Centre Hospitalier Universitaire de Toulouse (Toulouse University Hospital Centre); Centre Midi-Pyr\u00e9n\u00e9es de PharmacoVigilance, de Pharmaco\u00e9pid\u00e9miologie et d'Information sur le M\u00e9dicament (Midi-Pyrenees Centre for Pharmacovigilance, Pharmacoepidemiology and Drug Information); UMR INSERM 1027; Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thuy-Ngan","family":"Tran","sequence":"additional","affiliation":[{"name":"The National Centre of Drug Information and Adverse Drug Reaction Monitoring; Hanoi University of Pharmacy; Hanoi Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai-Loan T.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"The National Centre of Drug Information and Adverse Drug Reaction Monitoring; Hanoi University of Pharmacy; Hanoi Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoang-Anh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"The National Centre of Drug Information and Adverse Drug Reaction Monitoring; Hanoi University of Pharmacy; Hanoi Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Hoang-Anh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"The National Centre of Drug Information and Adverse Drug Reaction Monitoring; Hanoi University of Pharmacy; Hanoi Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinh-Hoa","family":"Vu","sequence":"additional","affiliation":[{"name":"The National Centre of Drug Information and Adverse Drug Reaction Monitoring; Hanoi University of Pharmacy; Hanoi Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van-Doan","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Centre of Allergology and Clinical Immunology; Bach Mai Hospital; Hanoi Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haleh","family":"Bagheri","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie M\u00e9dicale et Clinique (Medical and Clinical Pharmacology Laboratory); Facult\u00e9 de M\u00e9decine de l'Universit\u00e9 Paul-Sabatier (Faculty of Medicine, Paul-Sabatier University); Toulouse France"},{"name":"Centre Hospitalier Universitaire de Toulouse (Toulouse University Hospital Centre); Centre Midi-Pyr\u00e9n\u00e9es de PharmacoVigilance, de Pharmaco\u00e9pid\u00e9miologie et d'Information sur le M\u00e9dicament (Midi-Pyrenees Centre for Pharmacovigilance, Pharmacoepidemiology and Drug Information); UMR INSERM 1027; Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"issue":"6, Part 2","key":"10.1111\/jcpt.12754-BIB0001|jcpt12754-cit-0001","doi-asserted-by":"crossref","first-page":"S637","DOI":"10.1067\/mai.2000.106156","article-title":"Understanding drug allergies","volume":"105","author":"Gruchalla","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1111\/jcpt.12754-BIB0002|jcpt12754-cit-0002","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/187221308783399252","article-title":"Mechanisms of drug hypersensitivity reactions and the skin","volume":"2","author":"Kuljanac","year":"2008","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"10.1111\/jcpt.12754-BIB0003|jcpt12754-cit-0003","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1111\/jcpt.12754-BIB0004|jcpt12754-cit-0004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1111\/jcpt.12754-BIB0005|jcpt12754-cit-0005","doi-asserted-by":"crossref","first-page":"E2135","DOI":"10.3390\/ijms17122135","article-title":"Review of toxic epidermal necrolysis","volume":"17","author":"Harris","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1111\/jcpt.12754-BIB0006|jcpt12754-cit-0006","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaad.2011.09.029","article-title":"Toxic epidermal necrolysis: review of pathogenesis and management","volume":"66","author":"Downey","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1111\/jcpt.12754-BIB0007|jcpt12754-cit-0007","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/pds.2276","article-title":"Spontaneous adverse event reports of Stevens-Johnson syndrome\/toxic epidermal necrolysis: detecting associations with medications","volume":"21","author":"Papay","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1111\/jcpt.12754-BIB0008|jcpt12754-cit-0008","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2230.2006.02185.x","article-title":"Epidemiological study of severe cutaneous adverse drug reactions in a city district of China","volume":"31","author":"Li","year":"2006","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1111\/jcpt.12754-BIB0009|jcpt12754-cit-0009","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2230.2010.03922.x","article-title":"Cutaneous adverse drug reactions in a hospital-based Chinese population","volume":"36","author":"Huang","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1111\/jcpt.12754-BIB0010|jcpt12754-cit-0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.clindermatol.2005.11.010","article-title":"Allergic skin reactions in the tropics","volume":"24","author":"Naafs","year":"2006","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1111\/jcpt.12754-BIB0011|jcpt12754-cit-0011","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40264-015-0387-4","article-title":"Adverse drug reaction reporting in Africa and a comparison of individual case safety report characteristics between Africa and the rest of the world: analyses of spontaneous reports in VigiBase\u00ae","volume":"39","author":"Ampadu","year":"2016","journal-title":"Drug Saf"},{"issue":"1","key":"10.1111\/jcpt.12754-BIB0012|jcpt12754-cit-0012","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.1990.01670250049006","article-title":"The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients","volume":"126","author":"Chan","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1111\/jcpt.12754-BIB0013|jcpt12754-cit-0013","unstructured":"Ministry of Health National Guideline of Pharmacovigilance. According to Decision 2111\/QD-BYT from Ministry of Health (Vietnam) http:\/\/canhgiacduoc.org.vn\/SiteData\/3\/UserFiles\/HDQGCGD%20Final%2029_05_2015.pdf"},{"issue":"2","key":"10.1111\/jcpt.12754-BIB0014|jcpt12754-cit-0014","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40264-017-0598-y","article-title":"Overview of pharmacovigilance system in Vietnam: lessons learned in a resource-restricted country","volume":"41","author":"Nguyen","year":"2018","journal-title":"Drug Saf"},{"issue":"7","key":"10.1111\/jcpt.12754-BIB0015|jcpt12754-cit-0015","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s40264-016-0413-1","article-title":"Signal of gastrointestinal congenital malformations with antipsychotics after minimising competition bias: a disproportionality analysis using data from Vigibase(\u00ae)","volume":"39","author":"Montastruc","year":"2016","journal-title":"Drug Saf"},{"issue":"2","key":"10.1111\/jcpt.12754-BIB0016|jcpt12754-cit-0016","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004850-200203000-00006","article-title":"Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports","volume":"17","author":"Schillevoort","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"issue":"3-4","key":"10.1111\/jcpt.12754-BIB0017|jcpt12754-cit-0017","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.phrs.2008.07.003","article-title":"Allergic reactions to oral drugs: a case\/non-case study from an Italian spontaneous reporting database (GIF)","volume":"58","author":"Salvo","year":"2008","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1111\/jcpt.12754-BIB0018|jcpt12754-cit-0018","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.therap.2016.02.024","article-title":"Atteintes r\u00e9tiniennes iatrog\u00e8nes: \u00e9tude cas\/non cas dans la banque nationale de pharmacovigilance","volume":"71","author":"Bourgeois","year":"2016","journal-title":"Th\u00e9rapie"},{"key":"10.1111\/jcpt.12754-BIB0019|jcpt12754-cit-0019","unstructured":"WHO Collaborating Centre for International Drug Monitoring WHO Adverse Reaction Terminology (WHO-ART) http:\/\/www.umc-products.com\/"},{"issue":"1","key":"10.1111\/jcpt.12754-BIB0020|jcpt12754-cit-0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-199819010-00001","article-title":"The role of the WHO programme on International Drug Monitoring in coordinating worldwide drug safety efforts","volume":"19","author":"Olsson","year":"1998","journal-title":"Drug Saf"},{"key":"10.1111\/jcpt.12754-BIB0021|jcpt12754-cit-0021","unstructured":"US Department of Health and Human Services Common Terminology Criteria for Adverse Events (CTCAE) - version 4.03 https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/About.html"},{"issue":"1","key":"10.1111\/jcpt.12754-BIB0022|jcpt12754-cit-0022","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12754-BIB0023|jcpt12754-cit-0023","unstructured":"CRAN R: the R project for statistical computing https:\/\/www.r-project.org\/"},{"issue":"1","key":"10.1111\/jcpt.12754-BIB0024|jcpt12754-cit-0024","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","article-title":"Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel","volume":"58","author":"Halevy","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1111\/jcpt.12754-BIB0025|jcpt12754-cit-0025","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-4632.2010.04481.x","article-title":"Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia","volume":"49","author":"Ding","year":"2010","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1111\/jcpt.12754-BIB0026|jcpt12754-cit-0026","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4103\/0378-6323.16782","article-title":"Carbamazepine-the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: a study of 7\u00a0years","volume":"71","author":"Devi","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/jcpt.12754-BIB0027|jcpt12754-cit-0027","first-page":"4320195","article-title":"The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in China","volume":"2018","author":"Yang","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1111\/jcpt.12754-BIB0028|jcpt12754-cit-0028","first-page":"1","article-title":"Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: a case-control study","author":"Syu","year":"2018","journal-title":"J Dermatol"},{"issue":"6","key":"10.1111\/jcpt.12754-BIB0029|jcpt12754-cit-0029","first-page":"15","article-title":"Association of HLA-B*1502 allele and carbamazepine-induced severe adverse cutaneous drug reaction among Asians, a review","volume":"13","author":"Lim","year":"2008","journal-title":"Neurol Asia"},{"issue":"3","key":"10.1111\/jcpt.12754-BIB0030|jcpt12754-cit-0030","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/1756-185X.12050","article-title":"HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region","volume":"16","author":"Yeo","year":"2013","journal-title":"Int J Rheum Dis"},{"issue":"10","key":"10.1111\/jcpt.12754-BIB0031|jcpt12754-cit-0031","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jocn.2010.12.054","article-title":"Pharmacogenetic screening of carbamazepine-induced severe cutaneous allergic reactions","volume":"18","author":"Locharernkul","year":"2011","journal-title":"J Clin Neurosci"},{"key":"10.1111\/jcpt.12754-BIB0032|jcpt12754-cit-0032","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2350-12-118","article-title":"Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"12","author":"Somkrua","year":"2011","journal-title":"BMC Med Genet"},{"issue":"2","key":"10.1111\/jcpt.12754-BIB0033|jcpt12754-cit-0033","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5415\/apallergy.2015.5.2.68","article-title":"HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese","volume":"5","author":"Nguyen","year":"2015","journal-title":"Asia Pac Allergy"},{"issue":"3","key":"10.1111\/jcpt.12754-BIB0034|jcpt12754-cit-0034","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1533-2500.2011.00479.x","article-title":"HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain","volume":"12","author":"Kulkantrakorn","year":"2012","journal-title":"Pain Pract"},{"issue":"9","key":"10.1111\/jcpt.12754-BIB0035|jcpt12754-cit-0035","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/FPC.0b013e328330a3b8","article-title":"Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population","volume":"19","author":"Tassaneeyakul","year":"2009","journal-title":"Pharmacogenet Genomics"},{"issue":"9","key":"10.1111\/jcpt.12754-BIB0036|jcpt12754-cit-0036","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamadermatol.2013.4114","article-title":"Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"149","author":"Tangamornsuksan","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1111\/jcpt.12754-BIB0037|jcpt12754-cit-0037","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaad.2008.11.884","article-title":"Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole","volume":"60","author":"Wanat","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1111\/jcpt.12754-BIB0038|jcpt12754-cit-0038","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40780-016-0048-5","article-title":"Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database","volume":"2","author":"Abe","year":"2016","journal-title":"J Pharm Health Care Sci"},{"key":"10.1111\/jcpt.12754-BIB0039|jcpt12754-cit-0039","unstructured":"US Food and Drug Administration Drug safety and availability - FDA drug safety communication: FDA warns of rare but serious skin reactions with the pain reliever\/fever reducer acetaminophen https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm363041.htm"},{"key":"10.1111\/jcpt.12754-BIB0040|jcpt12754-cit-0040","unstructured":"Drug Administration of Vietnam Official dispatch No 687\/QLD-\u0110K\u202f: update about the risk of severe cutaneous adverse reactions induced by paracetamol http:\/\/canhgiacduoc.org.vn\/SiteData\/3\/UserFiles\/QLD%20so%20687%20paracetamol%202014_01_14.pdf"},{"issue":"2","key":"10.1111\/jcpt.12754-BIB0041|jcpt12754-cit-0041","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/bcp.13445","article-title":"The French Network of Regional Centres of Pharmacovigilance and the French Investigators for Adverse Skin Reactions to Drugs. Is acetaminophen associated with a risk of Stevens-Johnson syndrome and toxic epidermal necrolysis? Analysis of the French Pharmacovigilance Database: risk of Stevens-Johnson syndrome and toxic epidermal necrolysis with acetaminophen","volume":"84","author":"Lebrun-Vignes","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1111\/jcpt.12754-BIB0042|jcpt12754-cit-0042","first-page":"217","article-title":"Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in Southeast Asia","volume":"31","author":"Lee","year":"2013","journal-title":"Spec Issue Cutan Adverse Drug React"},{"key":"10.1111\/jcpt.12754-BIB0043|jcpt12754-cit-0043","unstructured":"Chu QT Trends on imported medicine and associated factors during 2006-2014 [Doctoral Thesis in Vietnamese Code 62.72.04.12] http:\/\/www.hup.edu.vn\/cpbdv\/psdh\/noidung\/Lists\/NghienCuuSinh\/View_Detail.aspx?ItemID=115"},{"key":"10.1111\/jcpt.12754-BIB0044|jcpt12754-cit-0044","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2050-6511-15-6","article-title":"Antibiotic sales in rural and urban pharmacies in northern Vietnam: an observational study","volume":"15","author":"Nga","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"issue":"4","key":"10.1111\/jcpt.12754-BIB0045|jcpt12754-cit-0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2332\/allergolint.O-07-483","article-title":"Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006","volume":"56","author":"Yamane","year":"2007","journal-title":"Allergol Int"},{"issue":"2","key":"10.1111\/jcpt.12754-BIB0046|jcpt12754-cit-0046","first-page":"216","article-title":"European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"18","author":"Fritsch","year":"2008","journal-title":"Eur J Dermatol"},{"issue":"4","key":"10.1111\/jcpt.12754-BIB0047|jcpt12754-cit-0047","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.mjafi.2013.01.007","article-title":"Severe cutaneous adverse drug reactions","volume":"69","author":"Verma","year":"2013","journal-title":"Med J Armed Forces India"},{"issue":"3","key":"10.1111\/jcpt.12754-BIB0048|jcpt12754-cit-0048","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.alit.2015.01.002","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: the Food and Drug Administration adverse event reporting system, 2004-2013","volume":"64","author":"Abe","year":"2015","journal-title":"Allergol Int"},{"issue":"5","key":"10.1111\/jcpt.12754-BIB0049|jcpt12754-cit-0049","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2125.2011.03933.x","article-title":"General principles of investigating and managing drug allergy","volume":"71","author":"Frew","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1111\/jcpt.12754-BIB0050|jcpt12754-cit-0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40264-015-0388-3","article-title":"Performance of stratified and subgrouped disproportionality analyses in spontaneous databases","volume":"39","author":"Seabroke","year":"2016","journal-title":"Drug Saf"},{"issue":"5","key":"10.1111\/jcpt.12754-BIB0051|jcpt12754-cit-0051","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1099-1557(199709\/10)6:5<313::AID-PDS292>3.0.CO;2-K","article-title":"Misclassification and selection bias in case-control studies using an automated database","volume":"6","author":"Evans","year":"1997","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1111\/jcpt.12754-BIB0052|jcpt12754-cit-0052","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/jech.44.3.179","article-title":"Bias in case-control studies. A review","volume":"44","author":"Kopec","year":"1990","journal-title":"J Epidemiol Community Health"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12754","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12754\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:03:59Z","timestamp":1671818639000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12754","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,20]]}}}